Stentrode is the only implantable brain-computer interface that does not require open brain surgery and is currently in clinical trials SAN FRANCISCO & NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE) ...

NEW YORK--(BUSINESS WIRE)--Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s Stentrode™ ...

Apple has partnered with brain-computer interface maker Synchron to develop tech that lets consumers control devices like iPhones with their thoughts, according to a report by the Wall Street Journal.

Synchron Inc.'s recent $2 million raise for its Stentrode brain-computer interface platform comes at a pivotal time for the technology. Advances in BCI development, ongoing clinical trials and growing ...

The brain-computer interface developer Synchron has laid out plans to build an artificial intelligence model trained on the language of cognition—instead of words or pictures—with programs that are ...

Apple has worked on a new standard with Synchron on a brain-computer interface that, among other things, aids folks with disabilities, according to the Wall Street Journal. Synchron has made a ...

BackgroundAlzheimer's disease (AD) is the most common neurodegenerative disorder, characterized by progressive cognitive decline and memory impairment ...

eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...